暂无分享,去创建一个
Olivia Choudhury | Amar Das | Issa Sylla | Noor Fairoza | I. Sylla | Amar K. Das | Olivia Choudhury | Noor Fairoza
[1] D. Goff,et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. , 2007, The American journal of cardiology.
[2] Hillol Sarker,et al. Enforcing Human Subject Regulations using Blockchain and Smart Contracts , 2018 .
[3] Raanan Arens,et al. A Randomized Trial of Adenotonsillectomy for Childhood Sleep Apnea , 2014 .
[4] Gordon S Doig,et al. Failure to report protocol violations in clinical trials: a threat to internal validity? , 2011, Trials.
[5] M. Neuhäuser,et al. The statistical analysis of a clinical trial when a protocol amendment changed the inclusion criteria , 2008, BMC medical research methodology.
[6] Vitalik Buterin. A NEXT GENERATION SMART CONTRACT & DECENTRALIZED APPLICATION PLATFORM , 2015 .
[7] Philippe Ravaud,et al. Blockchain technology for improving clinical research quality , 2017, Trials.
[8] B. Howard,et al. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials , 2009, Diabetes Care.
[9] Balaji Viswanathan,et al. Performance Benchmarking and Optimizing Hyperledger Fabric Blockchain Platform , 2018, 2018 IEEE 26th International Symposium on Modeling, Analysis, and Simulation of Computer and Telecommunication Systems (MASCOTS).
[10] A. Bhatt. Protocol deviation and violation , 2012, Perspectives in clinical research.
[11] Lisa Bero,et al. Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation , 2008, PLoS medicine.
[12] Rachael B. Zuckerman,et al. Measuring the Incidence, Causes, and Repercussions of Protocol Amendments , 2011 .
[13] Walter T Ambrosius,et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) , 2014, Clinical trials.
[14] Henry M. Kim,et al. Towards an Ontology-Driven Blockchain Design for Supply Chain Provenance , 2016, Intell. Syst. Account. Finance Manag..
[15] Philippe Genestier,et al. Blockchain for Consent Management in the eHealth Environment: A Nugget for Privacy and Security Challenges , 2017 .
[16] Arthur Gervais,et al. Do you Need a Blockchain? , 2018, 2018 Crypto Valley Conference on Blockchain Technology (CVCBT).
[17] Kenneth A Getz,et al. Assessing the Impact of Protocol Design Changes on Clinical Trial Performance , 2008, American journal of therapeutics.
[18] Satoshi Nakamoto. Bitcoin : A Peer-to-Peer Electronic Cash System , 2009 .
[19] Hyeon-Eui Kim,et al. Blockchain distributed ledger technologies for biomedical and health care applications , 2017, J. Am. Medical Informatics Assoc..
[20] Olivia Choudhury,et al. Auto-Generation of Smart Contracts from Domain-Specific Ontologies and Semantic Rules , 2018, 2018 IEEE International Conference on Internet of Things (iThings) and IEEE Green Computing and Communications (GreenCom) and IEEE Cyber, Physical and Social Computing (CPSCom) and IEEE Smart Data (SmartData).
[21] Douglas G Altman,et al. Comparison of protocols and registry entries to published reports for randomised controlled trials. , 2011, The Cochrane database of systematic reviews.
[22] L. Martin,et al. How much do clinical trials cost? , 2017, Nature Reviews Drug Discovery.
[23] Murtaza Dhuliawala,et al. What Happens When?: Interpreting Schedule of Activity Tables in Clinical Trial Documents , 2018, BCB.
[24] Andrew Lippman,et al. MedRec: Using Blockchain for Medical Data Access and Permission Management , 2016, 2016 2nd International Conference on Open and Big Data (OBD).
[25] Daniel Davis Wood,et al. ETHEREUM: A SECURE DECENTRALISED GENERALISED TRANSACTION LEDGER , 2014 .
[26] Thaier Hayajneh,et al. Healthcare Blockchain System Using Smart Contracts for Secure Automated Remote Patient Monitoring , 2018, Journal of Medical Systems.